Skip to content
value.today
Vaxxinity, Inc. logo

Vaxxinity, Inc.

VAXX
$95 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2021 ending year
value.today research
Net income
$-137 M
-228333.3% margin
value.today research
Employees
—

Vaxxinity, Inc. in brief

Vaxxinity, Inc. is a listed company in the Healthcare sector, based in the USA. Its last known market value was $95 M (January 2024); there is no current figure. In the year to Dec 2021 it had sales of $0 M and a net loss of $137 M. Its shares trade under the symbol VAXX (Nasdaq).

Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.

Vaxxinity, Inc. timeline

1 events, 2021
  1. 2021
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Vaxxinity, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$193 M$385 M$578 M$770 M20232024

World rank over time

▼ down 10,353 places since 2022
2022-01-07: #11341#11,34120222022-12-25: #18188#18,18820222023-07-30: #15380#15,38020232024-01-05: #21694#21,6942024

Rank in USA: #2,877 (Jan 2022) · #3,698 (Dec 2022) · #3,111 (Jul 2023) · #3,730 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-228333.3%
Operating margin
—
Return on equity
-107.0%
Liabilities / assets
22.9%

Annual results

Revenue
$0 M
Operating income
—
Net income
$-137 M

Dec-2021 ending year

Balance sheet

Total assets
$166 M
Total liabilities
$38 M
Total equity
$128 M

Dec-2021 ending year

Markets and events: Vaxxinity, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
166,304
2.39 days to cover
Shares sold short, last 24 reportsAll stocks →

Fails to deliver

  • : 95 shares at $0.02
  • : 100 shares at $0.02
  • : 2,040 shares
  • : 19,158 shares

Lobbying by Vaxxinity, Inc.#

$170 K spent on lobbying the US Congress and federal agencies in 2022, most often on health issues, aerospace and defense.

Lobbying, 2022
$170 K
#941 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2022
2026 so far
—
  • Health Issues4 reports
  • Aerospace3 reports
  • Defense3 reports
  • Manufacturing3 reports
  • Medical/Disease Research/Clinical Labs3 reports
  • Veterans3 reports

Lobbying firms hired in 2022

BUCHANAN INGERSOLL & ROONEY PC $170 K

Vaxxinity, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2022$170 K—4

H-1B hiring at Vaxxinity, Inc.#

1 labor condition applications certified in fiscal 2024 for 1 positions, at a median wage of $167 K a year.

Certified, FY2024
1
#1,911 among companies on value.today
Worker positions
1
Median wage offered
$167 K
a year, full-time
Applications filed
1
Vaxxinity, Inc.: most frequent H-1B job titles in fiscal 2024
Job titlePositionsMedian wage offered
Regulatory Affairs CMC Senior ManagerRegulatory Affairs Managers1$167 K

Where: Edison, NJ 1

Vaxxinity, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202411$167 K1
FY202311$167 K1

How Vaxxinity, Inc. compares in Healthcare

CompanyMarket capP/ENet marginRev. growth
Vaxxinity, Inc.🇺🇸$95 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Jan 5, 2024 (last known)
Annual results:
Dec-2021 ending year
Balance sheet:
Dec-2021 ending year
Profile updated:
Nov 15, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Vaxxinity, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Vaxxinity, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Vaxxinity, Inc.? Suggest a correction